Trial of the Week: REDUCE
Matt Duprey joins to discuss the 2018 JAMA article "The Effect of Haloperidol on Survival Among Critically Ill Adults with a High Risk of Delirium: the REDUCE Randomized Clinical Trial."
Pharmacy to Dose: The Critical Care Podcast
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Trial of the Week: REDUCE
Special Guest: Matt Duprey, PharmD, PhD, BCCCP
Matt Duprey joins to discuss the March Trial of the Week, published in 2018 in JAMA: “The Effect of Haloperidol on Survival Among Critically Ill Adults with a High Risk of Delirium: the REDUCE Randomized Clinical Trial.”
We review the history of antipsychotic pharmacotherapy treatment and prophylaxis in delirium, reviewing guideline recommendations from that time. Then we dive into the Trial of the Week: REDUCE trial and discuss its findings as well as study design. Would results be the same with another medication? Why is delirium research so challenging? Prevalent v. incident delirium? What’s the best outcome to measure? What questions still need answered? These questions and so much more are answered in today's episode.
Reference list: https://pharmacytodose.files.wordpress.com/2024/03/reduce-references.pdf
PharmacyToDose.Com
@PharmacyToDose
Learn more about your ad choices. Visit megaphone.fm/adchoices